Delivery Order SPE2DR25D2206-SPE2DR26F9EU3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,038.74 to AmerisourceBergen Drug Corp for Belbuca 450 MCG film in a quantity of 60 units. This order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a firm fixed-price procurement with no set-aside designation. The award was made competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Belbuca 600 mcg film (60 count) with a ceiling value of $1,123.96. This firm fixed price delivery order represents a non-competitive, non-set-aside award and is set for ultimate completion by October 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,743.95 delivery order for Belbuca 600 microgram film (60 units) on December 4, 2025, with a completion date of December 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a transactional procurement under AmerisourceBergen's broader relationship with the federal government's medical...
- The Defense Logistics Agency (DLA) awarded a $1,146.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Belbuca 750 micrograms film in quantities of 60 units. This non-set-aside competitive award was performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. Belbuca is a buccal film formulation of buprenorphine used for opioid pain management, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Belbuca 300 mcg film (60-count), with a ceiling value of $1,075.23. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,026.43 to AmerisourceBergen Drug Corp for 60 units of Belbuca 750 mcg film, a buprenorphine-based pain management pharmaceutical. Issued on July 31, 2025, with an ultimate completion date of August 1, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,093.70 to AmerisourceBergen Drug Corp for the supply of Belbuca 750 microgram film (60 count) on December 3, 2025, with completion scheduled for December 4, 2025. This non-competitive delivery order represents a firm fixed price transaction utilizing a competitively awarded indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,027.72 to AmerisourceBergen Drug Corp for BELBUCA 150 MCG film (60 units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitive award utilized firm fixed pricing and required no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Belbuca 600 microgram films (60 count). This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,683.50 with firm fixed pricing and an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9EU3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,774.31 to AmerisourceBergen Drug Corp for 60 units of Belbuca 900 micrograms film on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Belbuca is a buccal film formulation used for opioid pain management in opioid-tolerant patients, reflecting the DLA's ongoing need to supply pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen Drug Corp holds extensive prime contracts with the DLA to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support global military healthcare operations. The company's selection reflects its demonstrated capability to meet federal procurement requirements and deliver specialized pharmaceutical products efficiently through competitive contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/7/25 |